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Abstract
Background: This study aimed to document the outcome dimensions that physicians see as important in defining
cure from depression. The study also aimed to analyse physicians’ attitudes about depression and to find out
whether they affect their prescribing practices and/or the outcome dimensions that they view as important in
defining cure.
Methods: A 51-item questionnaire based on six validated scales was used to rate the importance of several
depression outcome dimensions. Physicians’ attitudes about depression were also assessed using the Depression
Attitude Scale. Overall, 369 Belgian physicians (264 general practitioners [GPs]; 105 psychiatrists) participated in the
DEsCRIBE™ survey.
Results: GPs and psychiatrists strongly agreed that functioning and depressive symptomatology were most
important in defining cure; anxious and somatic symptomatology was least important. GPs and psychiatrists
differed in their attitudes about depression (p <0.001). Logistic regression revealed that the attitudes of GPs - but
not psychiatrists - were significantly associated with their rates of antidepressant prescription (p < 0.001) and that
certain attitudes predicted which outcome dimensions were seen as important in defining cure.
Conclusions: Belgian GPs and psychiatrists strongly agreed on which criteria were important in defining cure from
depression but differed in their attitudes about depression. The outcome dimensions that were considered
important in defining cure were influenced by physicians’ attitudes - this was more pronounced in GPs than in
psychiatrists.
Background
In 2006, the US National Institute of Mental Health
published an article regarding the possibility of finding a
cure for mental disorders [1]. This paper was a call to
health practitioners to set themselves more ambitious
goals when treating patients with mental illness. More-
over, this initiative aimed to cause a paradigm shift in
perceptions of depression and its cure. While such an
effort is admirable the paper failed to take into account
the complexity of mental disorders such as depression
and the inadequacies in our current ability to monitor
and define the disease. Depression is multifactorial, and
its aetiology and presentation differ greatly from one
patient to the next. Furthermore, decades of research
have failed to find consistent biological markers for
depression or for its outcomes. To date, clinical and
sociodemographic characteristics, such as comorbid
anxiety, age or employment status, are the most consis-
tent prognostic factors in depression [2,3], while evalua-
tion of outcomes in depression has been limited to
changes in symptom severity and concepts such as
response, remission, recovery, relapse and recurrence
[4,5]. Remission is usually defined as a score of less or
equal to 7 on the Hamilton Depression Rating Scale (17
item version) or less or equal to 10 on the Montgom-
ery-Asberg Depression Rating Scale: remission is there-
fore defined only on the basis of absence of symptoms.
In reality, most patients with depression present with
comorbid somatic symptoms [6] or anxiety often reach-
ing a severity akin to that of an anxiety disorder or a
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somatoform disorder [7]. A recent study of patients with
major depressive disorder has illustrated that these
symptom clusters (pain, anxiety and depression) are
important in patients’ assessment of improvement [8].
Patients reportedly value symptom resolution, normali-
sation of function and quality of life (QoL) when asses-
sing whether their depression has remitted [9,10].
Additional evidence suggests that current definitions
of outcome are inadequate. For example, although many
psychiatrists believe anhedonia to be a core symptom of
depression, assessment of change during the treatment
of depression is usually limited to a decrease in negative
affect, while an increase in positive affect is neglected.
Furthermore, although the Diagnostic and Statistical
Manual of Mental Disorders (fourth edition) definition
of major depressive disorder includes a functional criter-
ion (i.e., symptoms cause clinically significant distress or
impairment in social, occupational or other important
areas of functioning), functioning is often neglected in
the inclusion criteria and the outcome measures of ran-
domised controlled trials (RCTs). In order to address
the limitations of existing outcome measures, a number
of published papers have begun to address the impor-
tance of QoL in quantifying patients’ response to antide-
pressant treatment [11,12]. QoL potentially represents a
generic, global outcome measure that allows comparison
of treatment effects across different disorders.
While we assert that the current narrow outcome defi-
nitions in the treatment of depression present only the
view of the medical field instead of the outcomes that
matter most to patients, there is presently a paucity of
published data on patients’ views of what constitutes a
good outcome in depression [13,10]. Moreover, the
views of individual physicians on the different dimen-
sions that are important in defining a good outcome are
also poorly documented. Kerr and colleagues [14] have
reported that the attitudes of general practitioners [GPs]
and psychiatrists towards depression and the treatment
of depression differ markedly and also determine their
prescribing practice and treatment outcomes. It is there-
fore expected that the attitudes of GPs and psychiatrists
are also likely to differ about how to define satisfactory
outcomes in depression treatment.
PROact® (PRognosis Optimisation by adequate custo-
mised therapy) is an initiative that aims to define cure
from depression by creating a therapeutic contract
between patients and physicians. This paper documents
the first part of PROact® - DEsCRIBE™ (DEfinition of
the CRIteria of BEing cured). In DEsCRIBE™ physicians
were asked to consider what they thought was impor-
tant in defining cure in patients with depression. In
addition, we analysed the attitudes of GPs and psychia-
trists concerning depression and whether their attitudes
affect their prescribing practices and/or predict the
outcome dimensions that are ranked highest when
defining cure from depression.
Methods
Study design
This study was conducted between March and August
2009. The Belgian Central Medical Database was used
to select a random sample of GPs and psychiatrists.
These physicians were contacted between March and
July 2009 by randomly assigned Lundbeck Belgium sales
representatives who asked about their willingness to par-
ticipate in the study. Any physician who declined to par-
ticipate was replaced with another physician drawn
randomly from the Central Medical Database.
Physicians who agreed to participate were asked to
complete a two-part, password-protected, electronic
web-based questionnaire. Part I included questions
regarding their demographic characteristics, clinical
experience and a query about whether they prescribe
antidepressants to ≤ 50% (low prescribers) or > 50%
(high prescribers) of their patients with depression. Part
I also required participants to complete the Depression
Attitude Scale (DAS) [15] which consists of 20 state-
ments regarding the physician’s attitudes about depres-
sion and its treatment. Physicians were asked to rate
their agreement with each statement of the DAS on a 5-
point Likert scale (where 1 = strongly agree and 5 =
strongly disagree).
Part II of the survey requested that physicians rate the
importance of 51 items in determining whether a
patient has been cured of depression (the DEsCRIBE™
questionnaire). Physicians rated each item on a 5-point
Likert scale (where 1 = not important and 5 = very
important). The six scales used in the DEsCRIBE™
questionnaire to measure depression, anxiety, somatic
symptoms, positive affect, functional impairment and
QoL were, respectively: the Patient Health Question-
naire-Depression subscale (PHQ-9; 9 items); the Hospi-
tal Anxiety and Depression Scale-Anxiety subscale
(HADS-A; 7 items); the Patient Health Questionnaire-
Somatic Symptoms subscale (PHQ-somatic; 13 items);
the Positive And Negative Affect Schedule-Positive
Affect subscale (PANAS-pos; 10 items); the Sheehan
Disability Scale (SDS; 3 items); and the Abbreviated
World Health Organization QoL scale (WHOQOL-
BREF; 9 items).
Statistical analysis
Results were summarised as mean and standard devia-
tion (SD) for quantitative variables and scores; frequency
tables were used for categorical findings. Mean values
were compared by one-way analysis of variance and pro-
portions were analysed by the chi-squared test. The 51
DEsCRIBE™ questionnaire items were ranked by
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decreasing mean score (i.e., by order of importance)
both for the whole sample and for GPs and psychiatrists
separately. Spearman’s rank correlation coefficients were
calculated to measure the association between the atti-
tude statements. A factor analysis based on the maxi-
mum likelihood principle and with varimax rotation was
applied separately to the attitude statements of GPs and
psychiatrists. This method allows selecting the exact
number of factors which explain at least 100% of the
common variance. These factors were subsequently ana-
lysed with respect to the demographic features and pre-
scribing behaviour of the physician (high vs. low
prescribers).
The association between the attitude factors and the
six DEsCRIBE™ outcome dimensions was also studied
by multiple regression analysis. Logistic regression was
used to assess the relationship between the prescribing
pattern of the physician (high vs low) and the attitude
factors. The association with each factor was expressed
in terms of the odds ratio (OR) and its 95% confidence
interval (CI). Results were considered statistically signifi-
cant at the 5% level (p < 0.05). Calculations were per-
formed using SAS (version 9.1 for Windows) and S-
PLUS (version 6.1) statistical packages.
Results
Study population
In total, 1240 physicians were contacted, of whom 369
completed the survey (response rate of 30%). The char-
acteristics of the physicians who completed the survey
and of the general Belgian physician population are
compared in Table 1. The mean age of the participating
physicians and of the Belgian physician population were
comparable, while the proportion of female physicians
was 7-14% lower in the study population vs. the Belgian
physician population.
Defining a patient who is cured of depression
Physicians were asked to rate the importance of each of
the 51 items of the multidimensional DEsCRIBE™ ques-
tionnaire in defining cure. Among the PHQ-9 depressive
symptoms, GPs and psychiatrists considered decreased
interest, depressed mood and suicidal ideation to be
most important in defining cure, whereas concentration,
appetite and psychomotor retardation/agitation were
considered to be least important (Table 2).
GPs and psychiatrists agreed strongly about the items
that were most and least important in defining cure
from depression (Table 3). The top 10 items for GPs
and psychiatrists comprised 3 PHQ-9 depression items,
3 WHOQOL-BREF items, 2 SDS items and 2 PANAS-
pos items. The 10 least important items were all PHQ-
somatic items.
The ranking of the mean scores for the six scales was
identical for GPs and psychiatrists, with the SDS and
PHQ-9 depression scales considered the two most
important scales in defining cure and the HADS-A and
PHQ-somatic considered the two least important scales
(Table 4).
Physicians’ attitudes about depression
Highly significant differences (p ≤ 0.001) were found
between the attitudes of GPs and psychiatrists for 10 of
the 20 statements on the DAS (Table 5). Several rela-
tions were noted between some DAS statements. For
example, “feeling comfortable treating patients with
depression” (A9) and “finding the experience rewarding”
(A15) were positively correlated in both groups of physi-
cians (r = 0.33, p < 0.001 for GPs and r = 0.34, p <
0.001 for psychiatrists). It is interesting to note that GPs
(but not psychiatrists) who are comfortable treating
patients with depression (A9) and find it rewarding
(A15) did not agree that an underlying biochemical
abnormality is causative for severe cases of depression
(A4) (r = -0.13, p < 0.05) and did not agree that psy-
chotherapy tends to be unsuccessful in patients with
depression (A16) (r = -0.13, p < 0.05). It is also interest-
ing to note that psychiatrists (but not GPs) who agree
that a nurse could be useful in supporting patients with
depression (A11) disagree that depression reflects a
characteristic response in patients that is not amenable
to change (A10) (r = -0.29, p < 0.01).
A maximum likelihood (with varimax rotation) factor
analysis of the DAS responses was performed separately
Table 1 Characteristics of study participants versus the Belgian physician populationa
Survey population Belgian physician population
Characteristic Psychiatrists (n = 105) GPs (n = 264) Psychiatrists (n = 1611) GPs (n = 14 888)
Female (%) 36 22 43 36
Practice: private/institutional/both (%) 17/16/67 96/4/0 - -
Mean age (years) 46 50 50 50
Mean duration of practice (years) 17 24 - -
Number of patients with depression treated each month 71 33 - -
GP, general practitioner.
aBased on physicians present in the Belgian Central Medical Database.
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Table 2 Ranking of the nine items of the PHQ-9 depressive symptomatology outcome dimension in terms of their
importance in defining cure from depression according to GPs and psychiatrists
Rank Psychiatrists Mean
score
GPs Mean
score
1 Little interest or pleasure in doing things 4.52 Little interest or pleasure in doing things 4.39
2 Feeling down, depressed, or hopeless 4.43 Feeling down, depressed, or hopeless 4.25
3 Thoughts that you would be better off dead or of hurting
yourself in some way
4.18 Thoughts that you would be better off dead or of hurting
yourself in some way
4.07
4 Trouble falling or staying asleep, or sleeping too much 4.09 Feeling bad about yourself, or that you are failure, or have
let yourself or your family down
4.00
5 Feeling tired or having little energy 4.03 Trouble falling or staying asleep, or sleeping too much 3.99
6 Feeling bad about yourself, or that you are failure, or have
let yourself or your family down
3.96 Feeling tired or having little energy 3.93
7 Trouble concentrating on things 3.96 Trouble concentrating on things 3.67
8 Moving or speaking so slowly that other people could have
noticed Or the opposite - being so fidgety or restless that
you have been moving around a lot more than usual
3.66 Poor appetite or overeating 3.25
9 Poor appetite or overeating 3.54 Moving or speaking so slowly that other people could have
noticed Or the opposite - being so fidgety or restless that
you have been moving around a lot more than usual
3.17
GPs, general practitioner.
Physicians were asked to rank the importance of each item from 1 to 5, with 5 indicating greatest importance.
Table 3 Most and least important statements in defining cure in patients with depression
Psychiatrists GPs
Item Mean score Item Mean score
10 most important items in defining cure
Little interest or pleasure in doing things 4.52 Little interest or pleasure in doing things 4.39
Occupational functioning 4.44 Feeling life is meaningful 4.37
Social functioning/leisure 4.44 Social functioning/leisure 4.36
Being able to enjoy life 4.44 Being able to enjoy life 4.30
Feeling down, depressed or hopeless 4.43 Occupational functioning 4.27
Interested 4.33 Feeling down, depressed or hopeless 4.25
Feeling life is meaningful 4.32 Not feeling blue, depressed or anxious 4.13
Active 4.25 Interested 4.12
Thoughts that one would be better off dead 4.18 Active 4.09
Being able to concentrate 4.13 Thoughts that one would be better off dead 4.07
10 least important items in defining cure
Stomach pain 2.66 Back pain 2.73
Dizziness 2.61 Dizziness 2.71
Back pain 2.58 Stomach pain 2.65
Pain in arms, legs or joints 2.47 Pain during intercourse 2.65
Shortness of breath 2.47 Shortness of breath 2.59
Constipation, loose bowels or diarrhoea 2.43 Pain in arms, legs or joints 2.48
Nausea, gas or indigestion 2.36 Nausea, gas or indigestion 2.48
Pain during intercourse 2.30 Fainting spells 2.31
Fainting spells 2.08 Constipation, loose bowels or diarrhoea 2.29
Menstrual pain 2.01 Menstrual pain 1.98
Physicians were asked to rank the importance of each item from 1 to 5, with 5 indicating greatest importance.
The 3 Diagnostic Statistical Manual of Mental Disorders criteria located in the top 10 are highlighted.
GP, general practitioner.
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for GPs and psychiatrists (Table 6). The analysis of GP
responses revealed a three-factor solution. The factors
were named after the statement with the highest loading
(coefficient) within each factor:
■ Factor 1: Depression is how people with poor sta-
mina deal with stress.
■ Factor 2: It is rewarding looking after patients with
depression.
Table 4 Importance of scales for assessing whether a
patient has been cured of depression
Psychiatrists GPs
Scale Rank Mean score Rank Mean score
SDS 1 4.23 1 4.13
PHQ-9 2 4.04 2 3.86
WHOQOL-BREF 3 3.86 3 3.84
PANAS-pos 4 3.79 4 3.72
HADS-A 5 3.34 5 3.22
PHQ-somatic 6 2.50 6 2.61
All physicians were asked to rank the importance of each item from 1 to 5,
with 5 indicating greatest importance - the total mean score for all items from
the scale was then calculated and used to rank the scales.
GP, general practitioner; HADS-A, Hospital Anxiety and Depression Scale-
Anxiety subscale; PHQ-9, Patient Health Questionnaire-Depression Subscale;
PHQ-somatic, Patient Health Questionnaire-Somatic Symptoms subscale;
PANAS-pos, Positive And Negative Affect Schedule-Positive Affect subscale;
SDS, Sheehan Disability Scale; WHOQOL-BREF, Abbreviated World Health
Organization Quality of Life scale.
Table 5 Depression Attitude Scale questionnaire results - only statements with a significant difference between GPs
and psychiatrists are shown
Statement Physicians who
agreed with the
statement (%)a
Psychiatrists GPs
A1. Since starting my practice, I have seen an increase in the number of patients presenting with depressive symptoms 54 82***
A3. Most depressive disorders seen in general practice improve without medication 20 16**
A4. An underlying biochemical abnormality is the basis of severe cases of depression 86 73*
A5. It is difficult to differentiate whether patients are presenting with unhappiness or a clinical depressive disorder that needs
treatment
11 29***
A8. Patients with depression are more likely to have experienced deprivation in early life than other people 54 37**
A9. I feel comfortable in dealing with the needs of patients with depression 87 55***
A10. Depression reflects a characteristic response in patients which is not amenable to change 2 7*
A12. The nurse could be a useful person to support patients with depression 87 53***
A13. Working with patients with depression is heavy going 46 68***
A14. There is little to be offered to those patients with depression who do not respond to treatment by GPs 10 23***
A15. It is rewarding looking after patients with depression 78 45***
A16. Psychotherapy tends to be unsuccessful in patients with depression 2 11**
A17. If patients with depression need antidepressants, they are better off with a psychiatrist than with a GP 54 3***
A18. Antidepressants usually produce a satisfactory result in the treatment of patients with depression in general practice 29 82***
A19. Psychotherapy for patients with depression should be left to a specialist 74 47***
A20. If psychotherapy was freely available, this would be more beneficial than antidepressants for most patients with
depression
12 26**
GP, general practitioner.
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 for differences between the physician groups.
aPhysicians who ‘tended to agree’ or ‘strongly agree’ with the statement on the Likert scale were compared to the others by the chi-square test.
Table 6 Factor analysis of Depression Attitude Scale
statements in GPs and psychiatrists - only attitude
statement with at least one loading ≥ 40 or ≤ -40 for any
of the factors are represented
Statement Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
GP Psych GPs Psych GP Psych Psych Psych
A2 36 2 -11 22 13 14 -8 47*
A3 18 -5 -42* -34 -26 4 -2 81*
A5 23 20 -45* 3 9 47* 1 6
A6 46* 25 2 21 3 -6 15 15
A7 70* 73* -13 9 -8 -4 -24 16
A8 42* 28 8 26 -19 16 5 30
A9 8 -7 47* 56* -25 -17 0 -10
A10 49* 36 -5 -10 29 40* 5 4
A14 20 -15 -19 8 44* 74* 8 -9
A15 -2 -6 48* 63* -23 8 1 -3
A16 -3 -17 -7 -10 55* 50* 1 9
A17 15 16 -32 16 9 -3 85* -1
A18 6 -1 40 12 7 -12 -55* 7
A19 18 -9 -17 40 23 -3 43* 12*
A20 30 22 -32 -17 -28 -17 6 44*
GP, general practitioner; Psych, psychiatrist.
*Statement loading ≥ 40 or ≤ -40.
Shading indicates highest scoring statements in each factor solution common
between GP and psychiatrists (for factors 1 to 3). This statement was then
used to name the solution as it is representative of an underlying theme in
the attitudes of the physicians surveyed.
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■ Factor 3: Depression has a poor outcome.
By contrast, the analysis of psychiatrist responses
revealed a five-factor solution. Three of these factors
(Factors 1 to 3) were basically the same as those identi-
fied for GPs as the statements with the highest loading
in Factors 1, 2 and 3 were the same for the psychiatrist
and GP groups. The two additional factors for psychia-
trists were:
■ Factor 4: Depression should be treated by
psychiatrists.
■ Factor 5: Depression in primary care often resolves
spontaneously (and needs psychotherapy rather than
medication).
Comparison of the scores for the five factors between
the two physician groups revealed that, compared with
psychiatrists, GPs believe more strongly that depression
is how people with poor stamina deal with stress (Factor
1; p < 0.0001) and that GPs feel it is less rewarding
treating patients with depression (Factor 2; p < 0.0001).
Moreover, GPs believe that there is little to offer to
patients with depression who do not respond to treat-
ment by GPs, but to a lesser extent than psychiatrists
(Factor 3; p < 0.0001) and more strongly disagree that
treating depression is the role of the psychiatrist (Factor
4; p < 0.0001). Compared with psychiatrists, GPs agree
more with the statement that most depressive disorders
in a primary care practice do not improve without med-
ication and they disagree less with the statement that
freely available psychotherapy would be more beneficial
than antidepressants (Factor 5; p < 0.0001).
Physician attitudes about depression and prescribing
patterns
The present survey indicated that more psychiatrists
than GPs are high prescribers of antidepressants - 69%
of psychiatrists and 37% of GPs prescribed antidepres-
sants to
> 50% of their patients with depression.
A logistic regression analysis with prescribing pattern
(high vs. low prescribers) as the dependent variable and
the three GP attitude factors and sociodemographic char-
acteristics as independent variables revealed a significant
association between GPs’ perceptions and their prescrib-
ing behaviour (p = 0.0067). Specifically, low prescribing
was predicted by GPs’ perception that looking after
patients with depression is not rewarding (Factor 2, OR =
0.69; 95% CI: 0.49 to 0.97) and that depression has a poor
outcome (Factor 3, OR = 0.62; 95% CI: 0.43 to 0.88).
A logistic regression analysis with prescribing pattern
as the dependent variable and the psychiatrists’ five
depression attitude factors and sociodemographic
characteristics as independent variables did not reveal
any significant relationship between the depression atti-
tude factors of psychiatrists and their prescribing beha-
viour (p = 0.068).
Physician attitudes about depression and the importance
of different outcome dimensions in defining cure
Six regression analyses were performed on the psychia-
trist (and GP) data in order to assess whether the five
(or three) depression attitude factors (in addition to gen-
der and age) predicted the relative importance of each
of the six outcome dimensions used in defining cure
(ranking based on the mean score on each outcome
dimension where 1 = lowest ranking and 6 = highest
ranking).
A significant model was found for only two of the six
outcome dimensions for psychiatrists. Psychiatrists who
attach a greater relative importance to somatic symptoma-
tology in defining cure agreed that it is rewarding looking
after patients with depression (Factor 2; OR = 0.36; 95%
CI: 0.16 to 0.82). Psychiatrists who attached a greater rela-
tive importance to functioning in defining cure agreed
that depression is how people with poor stamina deal with
stress (Factor 1; OR = 0.52; 95% CI: 0.33 to 0.81).
A significant model was found for five out of the six
outcome dimensions for GPs. GPs who attach a greater
relative importance to depressive symptomatology in
defining cure agreed more strongly that depression is
how people with poor stamina deal with stress in their
lives (Factor 1; OR = 0.64; 95% CI: 0.49 to 0.84). GPs
who think that anxious symptomatology is important in
defining cure disagreed more strongly that depression is
how people with poor stamina deal with stress in their
lives (Factor 1; OR = 1.31; 95% CI: 1.00 to 1.71) and dis-
agreed more strongly that depression has a poor outcome
(Factor 3; OR = 1.40; 95% CI: 1.04 to 1.89). GPs who
attach a greater relative importance to functioning in
defining cure agreed more strongly that depression is
how people with poor stamina deal with stress in their
lives (Factor 1; OR = 0.62; 95% CI: 0.47 to 0.82) and dis-
agreed more strongly that depression has a poor outcome
(Factor 3; OR = 1.36; 95% CI: 1.00 to 1.84). GPs who
think that positive affect is important in defining cure
disagreed more strongly that depression is how people
with poor stamina deal with stress in their lives (Factor 1;
OR = 1.77; 95% CI: 1.35 to 2.32). GPs who attach a
greater relative importance to QoL in defining cure were
more likely to be women (OR = 1.99; 95% CI: 1.10 to
3.61) and agreed more strongly that depression has a
poor outcome (Factor 3; OR = 0.62; 95% CI: 0.46 to 0.84).
Discussion
The primary study finding was that GPs and psychia-
trists give very similar responses when asked about
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which depressive symptoms and broader outcome
dimensions are most important in defining cure from
depression. Indeed, when the nine depression items of
the PHQ-9 were ranked by these physician groups, the
three most and least important items were identical. To
the best of our knowledge this is the first documented
comparison of GPs’ and psychiatrists’ opinions about
defining cure from depression.
The 10 most important items in defining cure com-
prised the PHQ-9 items of anhedonia, depressed mood
and suicidal ideation, the SDS items of occupational
functioning and social functioning, the WHO-QOL
items of being able to enjoy life, being able to concen-
trate and feeling life is meaningful and the PANAS-pos
items of being interested and being active. The 10 least
important items were all items from the somatic symp-
tom scale. This is a remarkable finding as the impor-
tance of painful and non-painful symptoms has recently
received a great deal of attention in the scientific litera-
ture [2,7,16,17].
Ranking the outcomes at the dimension level gives a
broader definition of what a useful outcome in clinical
practice might be. This contrasts with the narrow out-
come definitions espoused by RCTs, which tend to
focus on depression scale scores, response and remission
[18]. It has been documented that patients enrolled in
RCTs rarely typify the patients seen in clinical practice
[19], and our data illustrate that the concept of cure
encompasses more than can be captured by single scale
scores and the current notions of response and remis-
sion. This idea has been mooted previously in the pub-
lished literature [4,20] and has been stated particularly
elegantly by Linsey McGoey of the Said Business School,
University of Oxford: “Never before have the inadequa-
cies of RCTs been so apparent to so many. Yet equally,
never before have those in positions of authority - from
regulators, to NICE policy makers, to doctors - relied so
extensively on RCT evidence” [21]. Our data are indeed
an illustration of the previous statement since endpoints
in RCTs and endpoints in physicians’ view seem to be
very different.
The broader definition of cure from depression cham-
pioned here seems to agree largely with published data
reporting what patients consider to be important in
defining cure. Patients give highest priority to positive
mental health (optimism, vigour and self-confidence)
followed by feeling normal, a return to usual levels of
functioning at work or at home, feeling in emotional
control, participating in and enjoying relationships with
family and friends and, finally, the absence of depressive
symptoms [9].
Analysis of these broader outcome dimensions is also
instructive when looking at the concepts of relapse and
recurrence. Residual deficits after treatment should not
refer only to residual symptoms, rather they should
encompass impairments in social and occupational func-
tioning (even independently of depressive symptom
scores). These broader outcome dimensions have been
reported to be significant and independent risk factors
for relapse and recurrence [22-24].
A second finding of this study were the important dif-
ferences in attitudes about depression and its treatment
demonstrated by GPs and psychiatrists (as measured
using the DAS). Overall, psychiatrists have a more posi-
tive attitude towards depression and its treatment - this
has also been reported in a study based in Wales [14].
In the current study, a factor analysis gave a different
solution for GPs (3 factors) and psychiatrists (5 factors;
3 of them being the same as for the GPs). A 4-factor
solution was reported in a study of 72 GPs by Botega
and colleagues [15], where 3 of the 4 factors are mainly
comparable to 3 of the 5 factors reported here. Factors I
(antidepressant/psychotherapy), II (professional unease)
and III (inevitable course of depression) in the Botega
paper [15] correspond with Factors 2, 3 and 5 in our
sample. It is a matter of concern that GPs feel that
treating patients with depression is unrewarding (Factor
2) but it is interesting that GPs are pessimistic about
what to do if a patient does not respond to their treat-
ment (Factor 3) and that they feel most of their
depressed patients should be treated with antidepres-
sants (Factor 5).
The importance of physicians’ attitudes to depression
and their ability to manage this disorder effectively have
been commented upon previously [14,15,25]. For exam-
ple, one study [25] used a modified form of the DAS
and found that non-psychiatrist physicians in Taiwan
who were positive about the treatment of depression did
not display avoidant/helpless attitudes and had the best
scores in depression management. These findings sup-
port an earlier study of GPs in Scotland that also used
the DAS [26]. This study reported that pessimism asso-
ciated with the treatment of depression was linked to
unwillingness to become involved with managing
patients with depression, while confidence resulted in
earlier recognition of the disorder [26]. Feeling comfor-
table with treating depression was also linked to more
accurate diagnosis in a study of GPs in the north of
England [27]. This study concluded that the accurate
identification and appropriate management of depres-
sion by GPs was not an independent variable; instead it
differed with different physicians’ attitudes and skills
[27].
It is perhaps unsurprising that psychiatrists are more
comfortable treating patients with depression and find
the experience more rewarding than GPs as they are
specialists in this field. It has been reported that mental
health expertise among GPs is also helpful in improving
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their attitudes towards the treatment of depression. An
earlier study of GPs using the DAS revealed that physi-
cians who had gained postgraduate mental health quali-
fications were more optimistic about achieving positive
outcomes for their patients with depression and felt
more comfortable in assisting these patients [28]. By
contrast, a study of primary care physicians’ attitudes to
depression conducted in Brazil illustrates that a lack of
exposure to patients with depression has the opposite
effect [29]. The results of such surveys are useful as they
suggest that training and experience can influence physi-
cians’ comfort in dealing with depression. It should also
be considered that attitudes may influence participation
in training programmes and influence the patients that
physicians treat within their own practice. The finding
that psychiatrists’ attitudes do not appear to influence
how they treat their patients is harder to explain. Per-
haps the greater experience of psychiatrists concerning
mental illness leads them to be less influenced by perso-
nal attitudes.
A third finding of this study is that compared with
psychiatrists, GPs prescribe antidepressants to a much
smaller proportion of their patients with depression.
This could of course be due to lower severity of depres-
sion in the patients seen by GPs and/or by the fact that
in Belgium most patients first seek help for depression
in primary care and are often only treated by a specialist
when a first-line modality has failed. However, our data
suggest that prescribing patterns are also predicted by
physicians’ attitudes, although this was only the case for
GPs, not psychiatrists. To the best of our knowledge,
this is a novel finding that has not been previously
reported. Our study also indicates that low prescribing
in GPs (but not in psychiatrists) is predicted by the fol-
lowing attitudes: that it is not rewarding to look after
patients with depression (Factor 2) and that depression
has a poor outcome (Factor 3). Studies regarding the
relationship between physicians’ attitudes and their pre-
scribing patterns are scarce. Botega and colleagues [15]
identified a subgroup (n = 26/72) of high-prescribing
GPs. Analysis of low-dose prescribers among GPs in a
study in Wales [14] indicated that, compared with stan-
dard-dose prescribers, this group were more in favour of
psychotherapy as a treatment modality, agreed less
strongly that depression has a biological basis, and
agreed less strongly that depression could be treated
effectively with antidepressants. Dowrick and colleagues
[27] found that GPs’ attitudes (measured using the
DAS) did not predict the frequency with which they
prescribed antidepressants; however, more positive atti-
tudes regarding the biological basis of depression did
predict the class of antidepressants that they prescribed
(selective serotonin reuptake inhibitors). The present
data suggest that, for GPs at least, finding it rewarding
to look after patients with depression is correlated with
more positive attitudes towards psychotherapy and with
a less strong belief in a biological basis for depression.
One could therefore speculate that these physicians find
a good doctor-patient relationship more satisfying than
they do prescribing an antidepressant.
A final finding of our study was that the outcome
dimensions considered to be important in defining cure
from depression were associated with physicians’ atti-
tudes towards depression. This result was more pro-
nounced in GPs than in psychiatrists. It is difficult to
interpret this finding, especially as overall both physician
groups agreed strongly on the outcome dimensions that
were important in defining cure. Our perception is that
this result is consistent with the earlier finding that GPs
are more influenced by their attitudes about depression
than are psychiatrists. The data also suggest female GPs
attach more importance to QoL issues than their male
colleagues.
As with any survey, the findings reported here are
only valid for the physicians who participated. The char-
acteristics of physicians who declined to participate
were not described and comparison of basic demo-
graphic characteristics revealed that the survey popula-
tion consisted of a smaller percentage of women than
the general Belgian physician population. However, refu-
sal to participate is a universal issue in observational
studies and on this issue our study was no more or less
biased than any other study of similar methodology.
Our study asked physicians to rate whether they pre-
scribe antidepressants to ≤ 50% or > 50% of their
patients with depression. Responses to this question
could be subject to recall bias and may be influenced by
physicians’ attitudes. Furthermore, the types of patients
that are seen by psychiatrists and GPs differ. In Belgium,
patients with depression are initially treated by a GP
who then refers patients requiring second-line treatment
to a psychiatrist. Consequently, GPs may treat more
patients with depressive adjustment disorder while psy-
chiatrists see more patients with major depressive disor-
der. The attitudes, beliefs and treatment patterns of GPs
and psychiatrists are therefore likely to vary in response
to the differences in their respective patient populations.
Conclusions
The present study illustrates that (Belgian) GPs and psy-
chiatrists strongly agree on the criteria that are impor-
tant in defining cure from depression but strongly differ
in their attitudes towards depression. Psychiatrists pre-
scribe antidepressants to a larger proportion of their
patients with depression compared with GPs. Prescrib-
ing patterns are significantly influenced by physicians’
attitudes about depression, but only in GPs. The out-
come dimensions considered to be most important in
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defining cure are also influenced by physicians’ attitudes -
this finding was more pronounced for GPs than for psy-
chiatrists. Future research should address patients’ per-
ceptions of what defines cure and whether these attitudes
correspond with those of their physician. Such research
could even assess whether convergence or divergence
between physicians’ and patients’ expectations about cure
influences outcome or treatment satisfaction.
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